Researchers present data on ATF-NCS for the treatment of autosomal dominant hypocalcemia
Sep. 22, 2022
Autosomal dominant hypocalcemia (ADH) type 1 and 2 are disorders that affect calcium homeostasis caused by gain-of-function mutations in CaSR, which encodes the calcium-sensing receptor.
